Successful mobilization, intra-apheresis recruitment, and harvest of hematopoietic progenitor cells by addition of plerixafor and subsequent large-volume leukapheresis. - sprookjes - yvandenbroek - TriplyDB

Successful mobilization, intra-apheresis recruitment, and harvest of hematopoietic progenitor cells by addition of plerixafor and subsequent large-volume leukapheresis.

Successful mobilization, intra-apheresis recruitment, and harvest of hematopoietic progenitor cells by addition of plerixafor and subsequent large-volume leukapheresis.

http://www.wikidata.org/entity/Q37180930

about

The prognostic impact of peripheral blood progenitor cell dose following high-dose therapy and autologous stem cell transplant for hematologic malignancies.Hematopoietic growth factors in transfusion medicine and cellular therapy - part I.

P2860

Q38256923-DA5E9BAD-20C7-446A-96E5-9606277A7220 Q42085680-89AC659C-4BDE-4111-9E1E-C92948D4DA61

P2860

Successful mobilization, intra-apheresis recruitment, and harvest of hematopoietic progenitor cells by addition of plerixafor and subsequent large-volume leukapheresis.

http://www.wikidata.org/entity/Q37180930

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Successful mobilization, intra ...... nt large-volume leukapheresis.

@en

Successful mobilization, intra ...... nt large-volume leukapheresis.

@nl

type

label

Successful mobilization, intra ...... nt large-volume leukapheresis.

@en

Successful mobilization, intra ...... nt large-volume leukapheresis.

@nl

prefLabel

Successful mobilization, intra ...... nt large-volume leukapheresis.

@en

Successful mobilization, intra ...... nt large-volume leukapheresis.

@nl

P1433

Q37180930-4A521577-2295-48C1-9EE4-5663FF122170

P1476

Q37180930-BA2EA835-C622-4081-B128-8C45FD72216A

P2093

Q37180930-10159EE2-9FE4-450E-BF73-7D73B1990FB6

Q37180930-3CD5DD28-420F-453A-8669-3E255CD8FEDC

Q37180930-65EB8C8D-2214-48E6-92BB-219D57E2344F

Q37180930-7B564569-A5FF-4021-8CDD-D998B6C4E317

Q37180930-8FB36EC8-27DC-46C1-84C4-38242EE5465D

P2860

Q37180930-0C8BA73A-7394-4114-AC9C-018BB28141B9

Q37180930-1113F210-4699-43D1-9F9F-27306B387C0F

Q37180930-1DFD6E23-5FBB-4DE4-9B36-C5FBCD8D7814

Q37180930-3C8F2002-24C1-4B43-9467-6FF627622BAC

Q37180930-64598392-424F-415F-91FB-EEAE1B22E0BC

Q37180930-865F4B0F-EB6C-4CF5-A39A-380293E44E7E

Q37180930-92815DD2-C756-43F9-8BFB-D3DD92DC7968

Q37180930-93AE7964-CDB3-4603-8A54-02295CF1CB4D

Q37180930-9C93EDCE-8A8A-4D07-984A-C0DA3EB91421

Q37180930-A4F00C71-894B-4278-BC02-AA7F2A76740B

P304

Q37180930-B3973505-27C2-4A33-9DC6-5C6C29023F57

P31

Q37180930-E84AB8FA-7920-46A1-87D9-F3774215790E

P356

Q37180930-410CBA4D-5519-4F68-B349-9FFE186538AF

P433

Q37180930-001263AB-DA1B-4162-B95E-744F44BE9C9E

P478

Q37180930-4B0C0E55-4730-4227-9DE5-404FE0840E3D

P577

Q37180930-DF13C46F-E8E7-4996-9270-FADE8DFAA785

P698

Q37180930-B368B5DA-75D5-4200-AC5D-D0E816B0FF7A

P932

Q37180930-8377DF74-3464-4228-AD8E-7AA52ACC6873

P356

P1433

Transfusion Medicine and Hemotherapy

P1476

Successful mobilization, intra ...... nt large-volume leukapheresis.

@en

P2093

Andreas Günther

http://www.w3.org/2001/XMLSchema#string

Andreas Humpe

http://www.w3.org/2001/XMLSchema#string

Martin Gramatzki

http://www.w3.org/2001/XMLSchema#string

Natalie Schub

http://www.w3.org/2001/XMLSchema#string

Ute Buwitt-Beckmann

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor.

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

Peripheral blood progenitor cells for marrow reconstitution: mobilization and collection strategies.

Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.

Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantatio

Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.

Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis.

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.

Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation.

P304

251-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000354377

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24179473

http://www.w3.org/2001/XMLSchema#string

P932

3776470

http://www.w3.org/2001/XMLSchema#string